AARTI PHARMALABS
|
AARTI PHARMALABS Last 5 Year Income Statement History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|
| INCOME : | ||||
| Gross Sales | ₹1,945 Cr | ₹1,200 Cr | - | - |
| Sales | ₹1,927 Cr | ₹1,192 Cr | - | - |
| Job Work/ Contract Receipts | - | - | - | - |
| Processing Charges / Service Income | ₹8.70 Cr | - | - | - |
| Revenue from property development | - | - | - | - |
| Other Operational Income | ₹9.23 Cr | ₹7.91 Cr | - | - |
| Less: Excise Duty | - | - | - | - |
| Net Sales | ₹1,945 Cr | ₹1,200 Cr | - | - |
| EXPENDITURE : | ||||
| Increase/Decrease in Stock | ₹-125 Cr | ₹-49 Cr | - | - |
| Raw Material Consumed | ₹1,295 Cr | ₹687 Cr | - | - |
| Opening Raw Materials | ₹191 Cr | - | - | - |
| Purchases Raw Materials | ₹1,015 Cr | ₹714 Cr | - | - |
| Closing Raw Materials | ₹191 Cr | ₹191 Cr | - | - |
| Other Direct Purchases / Brought in cost | ₹281 Cr | ₹163 Cr | - | - |
| Other raw material cost | - | - | - | - |
| Power & Fuel Cost | ₹75 Cr | ₹90 Cr | - | - |
| Electricity & Power | ₹75 Cr | ₹42 Cr | - | - |
| Oil, Fuel & Natural gas | - | ₹46 Cr | - | - |
| Coals etc | - | - | - | - |
| Other power & fuel | - | ₹2.49 Cr | - | - |
| Employee Cost | ₹121 Cr | ₹85 Cr | - | - |
| Salaries, Wages & Bonus | ₹108 Cr | ₹85 Cr | - | - |
| Contributions to EPF & Pension Funds | ₹8.15 Cr | ₹0.28 Cr | - | - |
| Workmen and Staff Welfare Expenses | ₹5.18 Cr | ₹0.34 Cr | - | - |
| Other Employees Cost | - | - | - | - |
| Other Manufacturing Expenses | ₹99 Cr | ₹146 Cr | - | - |
| Sub-contracted / Out sourced services | - | - | - | - |
| Processing Charges | ₹41 Cr | ₹6.04 Cr | - | - |
| Repairs and Maintenance | ₹35 Cr | ₹22 Cr | - | - |
| Packing Material Consumed | - | ₹13 Cr | - | - |
| Other Mfg Exp | ₹23 Cr | ₹105 Cr | - | - |
| General and Administration Expenses | ₹30 Cr | ₹8.13 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Rent , Rates & Taxes | ₹5.07 Cr | ₹0.12 Cr | - | - |
| Insurance | ₹8.95 Cr | ₹6.50 Cr | - | - |
| Printing and stationery | - | - | - | - |
| Professional and legal fees | ₹5.33 Cr | ₹0.39 Cr | - | - |
| Traveling and conveyance | - | ₹0.95 Cr | - | - |
| Other Administration | ₹11 Cr | ₹0.16 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Selling and Distribution Expenses | ₹75 Cr | ₹27 Cr | - | - |
| Advertisement & Sales Promotion | ₹5.16 Cr | - | - | - |
| Sales Commissions & Incentives | ₹6.32 Cr | ₹5.97 Cr | - | - |
| Freight and Forwarding | ₹62 Cr | ₹21 Cr | - | - |
| Handling and Clearing Charges | ₹1.07 Cr | - | - | - |
| Other Selling Expenses | - | ₹0.41 Cr | - | - |
| Miscellaneous Expenses | ₹33 Cr | ₹0.34 Cr | - | - |
| Bad debts /advances written off | - | - | - | - |
| Provision for doubtful debts | ₹1.50 Cr | - | - | - |
| Losson disposal of fixed assets(net) | - | - | - | - |
| Losson foreign exchange fluctuations | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - |
| Other Miscellaneous Expenses | ₹32 Cr | ₹0.34 Cr | - | - |
| Less: Expenses Capitalised | - | - | - | - |
| Total Expenditure | ₹1,603 Cr | ₹995 Cr | ₹0.01 Cr | ₹0.01 Cr |
| Operating Profit (Excl OI) | ₹342 Cr | ₹205 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Other Income | ₹2.32 Cr | ₹4.19 Cr | - | - |
| Interest Received | ₹0.94 Cr | ₹0.01 Cr | - | - |
| Dividend Received | ₹1.25 Cr | ₹2.48 Cr | - | - |
| Profit on sale of Fixed Assets | ₹-0.06 Cr | ₹0.02 Cr | - | - |
| Profits on sale of Investments | - | - | - | - |
| Provision Written Back | - | - | - | - |
| Foreign Exchange Gains | - | - | - | - |
| Others | ₹0.19 Cr | ₹1.68 Cr | - | - |
| Operating Profit | ₹344 Cr | ₹209 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Interest | ₹21 Cr | ₹12 Cr | - | - |
| InterestonDebenture / Bonds | - | - | - | - |
| Interest on Term Loan | ₹21 Cr | - | - | - |
| Intereston Fixed deposits | - | - | - | - |
| Bank Charges etc | - | ₹12 Cr | - | - |
| Other Interest | - | ₹0.34 Cr | - | - |
| PBDT | ₹323 Cr | ₹197 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Depreciation | ₹63 Cr | ₹42 Cr | - | - |
| Profit Before Taxation & Exceptional Items | ₹261 Cr | ₹155 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Exceptional Income / Expenses | - | - | - | - |
| Profit Before Tax | ₹261 Cr | ₹155 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Provision for Tax | ₹67 Cr | ₹33 Cr | - | - |
| Current Income Tax | ₹56 Cr | ₹27 Cr | - | - |
| Deferred Tax | ₹8.17 Cr | ₹4.68 Cr | - | - |
| Other taxes | ₹3.13 Cr | ₹1.13 Cr | - | - |
| Profit After Tax | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Extra items | - | - | - | - |
| Minority Interest | - | - | - | - |
| Share of Associate | - | - | - | - |
| Other Consolidated Items | - | - | - | - |
| Consolidated Net Profit | ₹193 Cr | ₹122 Cr | ₹-0.01 Cr | ₹-0.01 Cr |
| Adjustments to PAT | - | - | - | - |
| Profit Balance B/F | ₹717 Cr | ₹-0.02 Cr | ₹-0.02 Cr | ₹-0.02 Cr |
| Appropriations | ₹911 Cr | ₹122 Cr | ₹-0.02 Cr | ₹-0.02 Cr |
| General Reserves | ₹1.90 Cr | ₹1.48 Cr | - | - |
| Proposed Equity Dividend | - | - | - | - |
| Corporate dividend tax | - | - | - | - |
| Other Appropriation | ₹1.31 Cr | ₹-596 Cr | - | - |
| Equity Dividend % | ₹40.00 | - | - | - |
| Earnings Per Share | ₹21.35 | ₹4,890.04 | ₹-0.18 | ₹-0.18 |
| Adjusted EPS | ₹21.35 | ₹4,890.04 | ₹-0.18 | ₹-0.18 |
Compare Income Statement of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹5,940.2 Cr | -0.1% | 11.4% | 51.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
| CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
| ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -0.1% |
11.4% |
51.6% |
| SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses
